Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.
Hakim JG, Thompson J, Kityo C, Hoppe A, Kambugu A, van Oosterhout JJ, Lugemwa A, Siika A, Mwebaze R, Mweemba A, Abongomera G, Thomason MJ, Easterbrook P, Mugyenyi P, Walker AS, Paton NI; Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team. Hakim JG, et al. Lancet Infect Dis. 2018 Jan;18(1):47-57. doi: 10.1016/S1473-3099(17)30630-8. Epub 2017 Nov 3. Lancet Infect Dis. 2018. PMID: 29108797 Free PMC article. Clinical Trial.
Prevalence and correlates of active syphilis and HIV co-Infection among sexually active persons aged 15-59 years in Zambia: Results from the Zambia Population-based HIV Impact Assessment (ZAMPHIA) 2016.
Solomon H, Moraes AN, Williams DB, Fotso AS, Duong YT, Ndongmo CB, Voetsch AC, Patel H, Lupoli K, McAuley JB, Mulundu G, Kasongo W, Mulenga L. Solomon H, et al. Among authors: mulenga l. PLoS One. 2020 Jul 24;15(7):e0236501. doi: 10.1371/journal.pone.0236501. eCollection 2020. PLoS One. 2020. PMID: 32706823 Free PMC article.
Measles immunity gaps among children and adolescents with HIV in Zambia despite high measles vaccination and antiretroviral therapy coverage.
Mutembo S, Yang Y, Carcelen A, Winter AK, Mwansa FD, Chilumba I, Mutale I, Chongwe G, Monze M, Mulundu G, Nkamba H, Mulenga L, Hayford K, Moss WJ. Mutembo S, et al. Among authors: mulenga l. AIDS. 2023 Nov 1;37(13):2021-2029. doi: 10.1097/QAD.0000000000003634. Epub 2023 Jun 28. AIDS. 2023. PMID: 37418463 Free PMC article.
Test negative case-control study of COVID-19 vaccine effectiveness for symptomatic SARS-CoV-2 infection among healthcare workers: Zambia, 2021-2022.
Mweso O, Simwanza J, Malambo W, Banda D, Fwoloshi S, Sinyange N, Yoo YM, Feldstein LR, Kapina M, Mulenga LB, Liwewe MM, Musonda K, Kapata N, Mwansa FD, Agolory S, Bobo P, Hines J, Chilengi R. Mweso O, et al. Among authors: mulenga lb. BMJ Open. 2023 Dec 10;13(12):e072144. doi: 10.1136/bmjopen-2023-072144. BMJ Open. 2023. PMID: 38072491 Free PMC article.
Comparison of HIV prevalence, incidence, and viral load suppression in Zambia population-based HIV impact assessments from 2016 and 2021.
Mulenga LB, Hines JZ, Stafford KA, Dzekedzeke K, Sivile S, Lindsay B, Chola M, Ussery F, Patel HK, Abimiku A, Birhanu S, Minchella PA, Stevens T Jr, Hanunka B, Chisenga T, Shibemba A, Fwoloshi S, Siame M, Mutukwa J, Chirwa L, Siwingwa M, Mulundu G, Agbakwuru C, Mapondera P, Detorio M, Agolory SG, Monze M, Bronson M, Charurat ME; for the ZAMPHIA 2021 Study Group. Mulenga LB, et al. AIDS. 2024 May 1;38(6):895-905. doi: 10.1097/QAD.0000000000003834. Epub 2024 Jan 15. AIDS. 2024. PMID: 38227572
First COVID-19 case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.
Simulundu E, Mupeta F, Chanda-Kapata P, Saasa N, Changula K, Muleya W, Chitanga S, Mwanza M, Simusika P, Chambaro H, Mubemba B, Kajihara M, Chanda D, Mulenga L, Fwoloshi S, Shibemba AL, Kapaya F, Zulu P, Musonda K, Monze M, Sinyange N, Mazaba ML, Kapin'a M, Chipimo PJ, Hamoonga R, Simwaba D, Ngosa W, Morales AN, Kayeyi N, Tembo J, Bates M, Orba Y, Sawa H, Takada A, Nalubamba KS, Malama K, Mukonka V, Zumla A, Kapata N. Simulundu E, et al. Among authors: mulenga l. Int J Infect Dis. 2021 Jan;102:455-459. doi: 10.1016/j.ijid.2020.09.1480. Epub 2020 Oct 6. Int J Infect Dis. 2021. PMID: 33035675 Free PMC article.
First 100 Persons with COVID-19 - Zambia, March 18-April 28, 2020.
Chipimo PJ, Barradas DT, Kayeyi N, Zulu PM, Muzala K, Mazaba ML, Hamoonga R, Musonda K, Monze M, Kapata N, Sinyange N, Simwaba D, Kapaya F, Mulenga L, Chanda D, Malambo W, Ngosa W, Hines J, Yingst S, Agolory S, Mukonka V. Chipimo PJ, et al. Among authors: mulenga l. MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1547-1548. doi: 10.15585/mmwr.mm6942a5. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33090982 Free PMC article.
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers-Zambia, July 2020.
Fwoloshi S, Hines JZ, Barradas DT, Yingst S, Siwingwa M, Chirwa L, Zulu JE, Banda D, Wolkon A, Nikoi KI, Chirwa B, Kampamba D, Shibemba A, Sivile S, Zyambo KD, Chanda D, Mupeta F, Kapina M, Sinyange N, Kapata N, Zulu PM, Makupe A, Mweemba A, Mbewe N, Ziko L, Mukonka V, Mulenga LB, Malama K, Agolory S. Fwoloshi S, et al. Among authors: mulenga lb. Clin Infect Dis. 2021 Sep 15;73(6):e1321-e1328. doi: 10.1093/cid/ciab273. Clin Infect Dis. 2021. PMID: 33784382 Free PMC article.
112 results